medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Authors instructions        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 10

<< Back Next >>

Ginecol Obstet Mex 2020; 88 (10)

Blood eosinophilia and ovarian cancer: Phase I study of diagnostic tests

Álvarez-Sánchez JG, Opina-Pérez AT
Full text How to cite this article

Language: Spanish
References: 9
Page: 686-691
PDF size: 205.11 Kb.


Key words:

Eosinophils, Ovarian cancer, Diagnostic test, Ovarian tumor, Hodgkin lymphoma, Colorectal cancer, Cervix diagnosis.

ABSTRACT

Objective: To identify the possible association between blood eosinophilia and diagnosis of ovarian cancer.
Materials and Methods: A retrospective cross-sectional phase 1 study of diagnostic test development was performed. Data were collected on the medical records of patients who consulted at San Vicente Foundation Hospital with a diagnosis of ovarian tumor from 01/01/2011 to 01/01/2016. All patients with a diagnostic impression of ovarian tumor with at least one hemoleukogram at admission were included and those medical records of patients with a history of atopy, who were currently studying with parasitosis or with diagnosis of Hodgkin Lymphoma, colorectal cancer, breast and cervix were excluded. Age, absolute number of eosinophils, histological subtype and stage of the disease were the variables studied. The quantitative variables were evaluated with the Kolmogorov-Smirnov tests and the Mann Whitney and χ2 test was applied to evaluate the qualitative variables.
Results: We found 99 files of patients with ovarian cancer: 11.1% with eosinophilia vs 6% in controls (p ‹ 0.197). The histological subtypes of germinal and epithelial cells were the most eosinophilic and stage III was the most associated (n = 19).
Conclusion: To design a phase I study in order to identify the association between eosinophilia and diagnosis of ovarian cancer epithelial subtype and germ cells is possible.


REFERENCES

  1. Barnholtz-Sloan JS, et al. Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. Am J Obs Gynecol. 2003; 189: 1120. doi: 10.1067/ S0002-9378(03)00579-9.

  2. https://gco.iarc.fr/today/data/factsheets/populations/170-colombia-fact-sheets.pdf

  3. Symptoms. Foundation for Women’s Cancer. http://www. foundationforwomenscancer.org/types-of-gynecologiccancers/ ovarian/symptoms/

  4. NCCN Clinical Practice Guidelines in Oncology. https://www. nccn.org/professionals/physician_gls/f_guidelines.asp

  5. Zurawski VR, et al. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Int J Cancer. 1988; 42 (5): 677-80. doi. 10.1002 /ijc.2910420507.

  6. Shah CA, et al. Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125. Cancer Epidemiol Biomarkers Prev. 2009; 18 (5): 1365-72. doi 10.1158/1055-9965.EPI-08-1034.

  7. Sakkal S, et al. Eosinophils in Cancer: Favourable or Unfavourable? Curr Med Chem. 2016; 23 (7): 650-66. Doi. 10.2174 / 0929867323666160119094313.

  8. Nolen BM, et al. Role of eotaxin-1 signaling in ovarian cancer. Clin Cander Res. 2009; 15 (8): 2647-56. doi: 10.1158 / 1078-0432.CCR-08-2024.

  9. Van Mens SP, et al. Eosinofilie bij een solide tumor: ovariumsarcoom. Ned Tijdschr Geneeskd. 2010; 154. https:// www.ntvg.nl/system/files/publications/a1031.pdf.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2020;88